Randall R. Miller

1.3k total citations
27 papers, 905 citations indexed

About

Randall R. Miller is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Randall R. Miller has authored 27 papers receiving a total of 905 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Pharmacology and 5 papers in Oncology. Recurrent topics in Randall R. Miller's work include Pharmacogenetics and Drug Metabolism (7 papers), Adipose Tissue and Metabolism (4 papers) and Pharmacological Effects and Assays (4 papers). Randall R. Miller is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Adipose Tissue and Metabolism (4 papers) and Pharmacological Effects and Assays (4 papers). Randall R. Miller collaborates with scholars based in United States, Türkiye and Canada. Randall R. Miller's co-authors include Ralph A. Stearns, Byron H. Arison, Gary H. Rasmusson, Charles J. Waechter, Dennis Dean, Thomas A. Baillie, Ali Shafiee, Haideh Motamedi, Wei Tang and William P. Feeney and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Bacteriology.

In The Last Decade

Randall R. Miller

27 papers receiving 849 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Randall R. Miller United States 18 409 249 151 120 114 27 905
Robert T. Fischer United States 17 665 1.6× 153 0.6× 144 1.0× 94 0.8× 74 0.6× 20 965
Paul J. Ciaccio United States 18 740 1.8× 236 0.9× 262 1.7× 55 0.5× 79 0.7× 29 1.3k
Natallia Strushkevich Belarus 15 462 1.1× 461 1.9× 156 1.0× 103 0.9× 317 2.8× 42 1.2k
Paul Rowland United Kingdom 17 712 1.7× 292 1.2× 180 1.2× 96 0.8× 36 0.3× 29 1.3k
Patria Danielson United States 10 442 1.1× 264 1.1× 163 1.1× 41 0.3× 42 0.4× 11 971
Daniel P. Walker Australia 16 510 1.2× 247 1.0× 142 0.9× 267 2.2× 62 0.5× 49 1.3k
Charles W. Locuson United States 22 312 0.8× 513 2.1× 297 2.0× 102 0.8× 59 0.5× 44 989
Yuzo Yoshida Japan 18 570 1.4× 251 1.0× 85 0.6× 51 0.4× 33 0.3× 37 945
Richard Svensson Sweden 18 491 1.2× 176 0.7× 184 1.2× 210 1.8× 29 0.3× 42 1.1k
Marie‐Agnès Sari France 19 674 1.6× 189 0.8× 121 0.8× 106 0.9× 29 0.3× 39 1.5k

Countries citing papers authored by Randall R. Miller

Since Specialization
Citations

This map shows the geographic impact of Randall R. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randall R. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randall R. Miller more than expected).

Fields of papers citing papers by Randall R. Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randall R. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randall R. Miller. The network helps show where Randall R. Miller may publish in the future.

Co-authorship network of co-authors of Randall R. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Randall R. Miller. A scholar is included among the top collaborators of Randall R. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randall R. Miller. Randall R. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doss, George A., Randall R. Miller, Zhoupeng Zhang, et al.. (2005). Metabolic Activation of a 1,3-Disubstituted Piperazine Derivative:  Evidence for a Novel Ring Contraction to an Imidazoline. Chemical Research in Toxicology. 18(2). 271–276. 27 indexed citations
2.
Palucki, Brenda L., Ravi P. Nargund, Rui Tang, et al.. (2005). 2-Piperazinecarboxamides as potent and selective melanocortin subtype-4 receptor agonists. Bioorganic & Medicinal Chemistry Letters. 15(8). 1993–1996. 18 indexed citations
3.
Day, Stephen H., et al.. (2005). A semi-automated method for measuring the potential for protein covalent binding in drug discovery. Journal of Pharmacological and Toxicological Methods. 52(2). 278–285. 50 indexed citations
4.
Miller, Randall R., George A. Doss, & Ralph A. Stearns. (2004). IDENTIFICATION OF A HYDROXYLAMINE GLUCURONIDE METABOLITE OF AN ORAL HYPOGLYCEMIC AGENT. Drug Metabolism and Disposition. 32(2). 178–185. 14 indexed citations
5.
Tang, Wei, Ralph A. Stearns, Randall R. Miller, et al.. (2002). Metabolism of a Thiazole Benzenesulfonamide Derivative, a Potent and Selective Agonist of the Human β3-Adrenergic Receptor, in Rats: Identification of a Novel Isethionic Acid Conjugate. Drug Metabolism and Disposition. 30(7). 778–787. 8 indexed citations
6.
Biftu, Tesfaye, Mari R. Candelore, Margaret A. Cascieri, et al.. (2000). Discovery of an orally bioavailable alkyl oxadiazole β3 adrenergic receptor agonist. Bioorganic & Medicinal Chemistry Letters. 10(13). 1427–1429. 15 indexed citations
7.
Mathvink, Robert J., Mari R. Candelore, Margaret A. Cascieri, et al.. (2000). Discovery of a Potent, Orally Bioavailable β3 Adrenergic Receptor Agonist, (R)-N-[4-[2-[[2-Hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4-[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide. Journal of Medicinal Chemistry. 43(21). 3832–3836. 51 indexed citations
8.
Ngui, Jason S., Wei Tang, Ralph A. Stearns, et al.. (2000). Cytochrome P450 3A4-Mediated Interaction of Diclofenac and Quinidine. Drug Metabolism and Disposition. 28(9). 1043–1050. 58 indexed citations
9.
Shih, Thomas L., Mari R. Candelore, Margaret A. Cascieri, et al.. (1999). L-770,644: A potent and selective human β3 adrenergic receptor agonist with improved oral bioavailability. Bioorganic & Medicinal Chemistry Letters. 9(9). 1251–1254. 41 indexed citations
10.
Parmee, Emma R., Elizabeth M. Naylor, Vincent J. Colandrea, et al.. (1999). Human β3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamides. Bioorganic & Medicinal Chemistry Letters. 9(5). 749–754. 25 indexed citations
11.
Tang, Wei, Ralph A. Stearns, Gloria Y. Kwei, et al.. (1999). Interaction of Diclofenac and Quinidine in Monkeys: Stimulation of Diclofenac Metabolism. Journal of Pharmacology and Experimental Therapeutics. 291(3). 1068–1074. 61 indexed citations
12.
Thompson, Kathryn, S H Vincent, Randall R. Miller, et al.. (1997). Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.. PubMed. 25(10). 1113–8. 37 indexed citations
13.
Shafiee, Ali, Haideh Motamedi, Francis J. Dumont, Byron H. Arison, & Randall R. Miller. (1997). Chemical and Biological Characterization of Two FK506 Analogs Produced by Targeted Gene Disruption in Streptomyces sp. MA6548.. The Journal of Antibiotics. 50(5). 418–423. 14 indexed citations
14.
Leung, Kwan, Dosinda Cohn, Randall R. Miller, et al.. (1996). Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.. Drug Metabolism and Disposition. 24(7). 753–760. 8 indexed citations
15.
Motamedi, Haideh, Ali Shafiee, Sheng‐Jian Cai, et al.. (1996). Characterization of methyltransferase and hydroxylase genes involved in the biosynthesis of the immunosuppressants FK506 and FK520. Journal of Bacteriology. 178(17). 5243–5248. 66 indexed citations
16.
Huskey, Su-Er W., et al.. (1995). Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride.. Drug Metabolism and Disposition. 23(10). 1126–1135. 54 indexed citations
17.
Yost, Susan E., et al.. (1995). Flanking and Intragenic Sequences Regulating the Expression of the Rabbit α-Globin Gene. Journal of Biological Chemistry. 270(8). 3965–3973. 16 indexed citations
18.
Balani, Suresh K., et al.. (1995). Metabolites of L-735,524, a potent HIV-1 protease inhibitor, in human urine.. Drug Metabolism and Disposition. 23(2). 266–270. 55 indexed citations
19.
Miller, Randall R. & Charles J. Waechter. (1984). Structural features and some binding properties of proteoheparan sulfate enzymatically labeled by calf brain microsomes. Archives of Biochemistry and Biophysics. 228(1). 247–257. 4 indexed citations
20.
Miller, Randall R., Mark S. Kuhlenschmidt, C J Coffee, Ingrid Kuo, & Robert H. Glew. (1976). Comparison of the chemical, physical, and survival properties of normal and Z-variant alpha-1-antitrypsins.. Journal of Biological Chemistry. 251(15). 4751–4757. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026